{
    "clinical_study": {
        "@rank": "1565", 
        "acronym": "ICI-VPH", 
        "arm_group": [
            {
                "arm_group_label": "2 dose of quadrivalent HPV vaccine", 
                "arm_group_type": "No Intervention", 
                "description": "The participants who have already received 2 doses of the quadrivalent HPV vaccine (0, 6 months schedule) 5 years before recruitment will not receive an additional dose."
            }, 
            {
                "arm_group_label": "3 doses of quadrivalent HPV vaccine", 
                "arm_group_type": "Experimental", 
                "description": "The participants will receive a 3rd dose of quadrivalent HPV vaccine at recruitment visit, which is 5 years after having received two doses of vaccine given 6 months apart in grade 4 (0, 6, 60 months Schedule)"
            }
        ], 
        "brief_summary": {
            "textblock": "This randomised clinical trial aims to determine whether an immunization schedule comprising\n      two doses of Gardasil administered six months apart is non-inferior to a schedule comprising\n      three doses administered at 0, 6 and 60 months for the prevention of HPV-16 and HPV-18\n      infections that persist for at least six months, up to ten years after the initial\n      vaccination.\n\n      The study hypothesis is that the two-dose schedule would offer similar protection as that of\n      a three-dose schedule against persistent HPV-16/18 infections."
        }, 
        "brief_title": "ICI-VPH: Impact of HPV Immunisation Schedules Against HPV", 
        "condition": "Human Papillomavirus Infections", 
        "condition_browse": {
            "mesh_term": [
                "Warts", 
                "Papillomavirus Infections"
            ]
        }, 
        "eligibility": {
            "criteria": {
                "textblock": "Inclusion Criteria:\n\n          -  Having received two doses of Gardasil in 2008-2009, 2009-2010 or 2010-2011 according\n             to 0, 6 months Schedule (+- 1 month)\n\n          -  Resident of the regions chosen for the study\n\n        Exclusion Criteria:\n\n          -  Being considered immunosuppressed at time of vaccination (9-10 years-old) or at\n             recruitment visit\n\n          -  Being pregnant at recruitment visit"
            }, 
            "gender": "Female", 
            "healthy_volunteers": "Accepts Healthy Volunteers", 
            "maximum_age": "16 Years", 
            "minimum_age": "14 Years"
        }, 
        "firstreceived_date": "December 9, 2013", 
        "has_expanded_access": "No", 
        "id_info": {
            "nct_id": "NCT02009800", 
            "org_study_id": "ICI-VPH-1"
        }, 
        "intervention": {
            "arm_group_label": "3 doses of quadrivalent HPV vaccine", 
            "intervention_name": "Quadrivalent HPV vaccine", 
            "intervention_type": "Biological", 
            "other_name": "Gardasil"
        }, 
        "is_fda_regulated": "No", 
        "lastchanged_date": "December 9, 2013", 
        "location": [
            {
                "facility": {
                    "address": {
                        "city": "Montr\u00e9al", 
                        "country": "Canada", 
                        "state": "Quebec", 
                        "zip": "H2W 1T8"
                    }, 
                    "name": "Centre Hospitalier Uiversitaire de Montr\u00e9al"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Qu\u00e9bec", 
                        "country": "Canada", 
                        "state": "Quebec", 
                        "zip": "G1R 2J6"
                    }, 
                    "name": "Centre Hospitalier Universitaire de Qu\u00e9bec, CHU de Qu\u00e9bec"
                }
            }
        ], 
        "location_countries": {
            "country": "Canada"
        }, 
        "number_of_arms": "2", 
        "official_title": "ICI-VPH: Impact Des Calendriers d'Immunisation Contre Les HPV", 
        "overall_status": "Enrolling by invitation", 
        "oversight_info": {
            "authority": "Canada: Health Canada", 
            "has_dmc": "Yes"
        }, 
        "phase": "Phase 3", 
        "primary_completion_date": {
            "#text": "December 2020", 
            "@type": "Anticipated"
        }, 
        "primary_outcome": {
            "measure": "Incidence of persistent HPV-16/18 infections", 
            "safety_issue": "No", 
            "time_frame": "5 years after recruitment visite"
        }, 
        "required_header": {
            "download_date": "ClinicalTrials.gov processed this data on June 04, 2014", 
            "link_text": "Link to the current ClinicalTrials.gov record.", 
            "url": "http://clinicaltrials.gov/show/NCT02009800"
        }, 
        "responsible_party": {
            "investigator_affiliation": "Centre Hospitalier Universitaire de Qu\u00e9bec, CHU de Qu\u00e9bec", 
            "investigator_full_name": "Chantal Sauvageau", 
            "investigator_title": "Co-principal investigator", 
            "responsible_party_type": "Principal Investigator"
        }, 
        "secondary_outcome": {
            "measure": "Geometric mean titres of antibodies and seropositivity for HPV types 6, 11, 16 and 18", 
            "safety_issue": "No", 
            "time_frame": "5 years after recruitment visit"
        }, 
        "source": "Centre Hospitalier Universitaire de Qu\u00e9bec, CHU de Qu\u00e9bec", 
        "sponsors": {
            "collaborator": [
                {
                    "agency": "Centre Hospitalier Universitaire de Montr\u00e9al", 
                    "agency_class": "Other"
                }, 
                {
                    "agency": "Quebec National Public Health Institute", 
                    "agency_class": "Other"
                }, 
                {
                    "agency": "Quebec Ministry of Health and Social Services", 
                    "agency_class": "Other"
                }
            ], 
            "lead_sponsor": {
                "agency": "Centre Hospitalier Universitaire de Qu\u00e9bec, CHU de Qu\u00e9bec", 
                "agency_class": "Other"
            }
        }, 
        "start_date": "November 2013", 
        "study_design": "Primary Purpose: Prevention", 
        "study_type": "Interventional", 
        "verification_date": "December 2013"
    }
}